文献速递自身免疫性与大疱性皮肤病皮肤肿瘤

寻常型天疱疮与血液系统恶性肿瘤的关联:基于11,859例人群研究

Pemphigus and hematologic malignancies: A population-based study of 11,859 patients.
PubMed 文献 · J Am Acad Dermatol · 2017-12-02

该横断面研究比较1,985例天疱疮患者与9,874例年龄、性别、族裔匹配对照的6种血液恶性肿瘤患病率。天疱疮组慢性白血病、多发性骨髓瘤和非霍奇金淋巴瘤患病率显著更高,慢性白血病关联在调整免疫抑制治疗后仍显著,其他类型无显著关联。

要点

  • 天疱疮患者慢性白血病患病率0.9% vs 0.4%,OR 2.1(95%CI 1.2-3.6)。
  • 多发性骨髓瘤患病率0.8% vs 0.4%,OR 2.2(95%CI 1.2-3.9)。
  • 非霍奇金淋巴瘤患病率1.8% vs 1.2%,OR 1.5(95%CI 1.0-2.2)。

核心结论

  • 天疱疮与慢性白血病、多发性骨髓瘤和非霍奇金淋巴瘤存在显著关联。
  • 慢性白血病关联在调整免疫抑制治疗后仍显著(调整OR 2.0,95%CI 1.1-3.7)。

研究设计与样本

  • 横断面研究,比较天疱疮患者与年龄、性别、族裔匹配对照的6种血液恶性肿瘤患病率。
  • 纳入1,985例天疱疮患者和9,874例对照。

主要发现

  • 慢性白血病患病率0.9% vs 0.4%,OR 2.1(95%CI 1.2-3.6)。
  • 多发性骨髓瘤患病率0.8% vs 0.4%,OR 2.2(95%CI 1.2-3.9)。
  • 非霍奇金淋巴瘤患病率1.8% vs 1.2%,OR 1.5(95%CI 1.0-2.2)。
  • 急性白血病、霍奇金淋巴瘤、骨髓增生异常综合征和真性红细胞增多症与天疱疮无显著关联。

关键数值与推荐

  • 慢性白血病:OR 2.1(95%CI 1.2-3.6),调整免疫抑制治疗后调整OR 2.0(95%CI 1.1-3.7)。
  • 多发性骨髓瘤:OR 2.2(95%CI 1.2-3.9)。
  • 非霍奇金淋巴瘤:OR 1.5(95%CI 1.0-2.2)。

临床怎么用

  • 对天疱疮患者应关注慢性白血病、多发性骨髓瘤和非霍奇金淋巴瘤的筛查与监测。

局限性

  • 天疱疮诊断缺乏免疫病理学验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The association of nonparaneoplastic pemphigus with comorbid hematologic malignancies has yet to be established. OBJECTIVE: To estimate the association between pemphigus and the common types of hematologic malignancies. METHODS: A cross-sectional study was conducted comparing pemphigus patients with age-, sex- and ethnicity-matched control subjects regarding the prevalence of 6 comorbid hematologic malignancies. The study was performed using the computerized database of Clalit Health Services ensuring the availability of 4.5 million patients. RESULTS: The study included 1985 pemphigus patients and 9874 control subjects. The prevalence of chronic leukemia (0.9% vs 0.4%, odds ratio [OR] 2.1, 95% confidence interval [CI] 1.2-3.6), multiple myeloma (0.8% vs 0.4%, OR 2.2, 95% CI 1.2-3.9), and non-Hodgkin lymphoma (1.8% vs 1.2%, OR 1.5, 95% CI 1.0-2.2) was greater in patients with pemphigus than in controls. The association with chronic leukemia remained significant following the adjustment for immunosuppressive therapy (adjusted OR 2.0, 95% CI 1.1-3.7). No significant associations were observed between pemphigus and acute leukemia, Hodgkin lymphoma, myelodysplastic syndrome, and polycythemia vera. LIMITATIONS: Lack of immunopathologic validation of the diagnosis of pemphigus. CONCLUSION: A significant association was observed between pemphigus and chronic leukemia, multiple myeloma, and non-Hodgkin lymphoma. Further research is warranted to establish this observation in other cohorts.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Kridin K, Zelber-Sagi S, Comaneshter D, et al. Pemphigus and hematologic malignancies: A population-based study of 11,859 patients. J Am Acad Dermatol. 2017. PMID: 29198780. doi:10.1016/j.jaad.2017.11.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。